Literature DB >> 11897139

Nucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis.

Débora M Santana1, Gulnara P Borja-Cabrera, Edilma Paraguai de Souza, Nancy R Sturm, Clarisa B Palatnik de Sousa, David A Campbell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11897139     DOI： 10.1016/s0166-6851(02)00010-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  17 in total

1.  Ability of immunodiagnostic tests to differentiate between dogs naturally infected with Leishmania infantum and Leishmune(®)-vaccinated dogs.

Authors:  R A N Ribeiro; R G Teixeira-Neto; V S Belo; E C Ferreira; H D F H Schallig; E S Silva
Journal:  Vet Res Commun       Date:  2015-02-11       Impact factor: 2.459

2.  Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis.

Authors:  Ingrid Aguilar-Be; Renata da Silva Zardo; Edilma Paraguai de Souza; Gulnara Patrícia Borja-Cabrera; Miguel Rosado-Vallado; Mirza Mut-Martin; Maria del Rosario García-Miss; Clarisa Beatriz Palatnik de Sousa; Eric Dumonteil
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

3.  Analysis of Bacillus anthracis nucleoside hydrolase via in silico docking with inhibitors and molecular dynamics simulation.

Authors:  Ana P Guimarães; Aline A Oliveira; Elaine F F da Cunha; Teodorico C Ramalho; Tanos C C França
Journal:  J Mol Model       Date:  2011-02-12       Impact factor: 1.810

4.  Adaptive immunity against Leishmania nucleoside hydrolase maps its c-terminal domain as the target of the CD4+ T cell-driven protective response.

Authors:  Dirlei Nico; Carla Claser; Gulnara P Borja-Cabrera; Luiz R Travassos; Marcos Palatnik; Irene da Silva Soares; Mauricio Martins Rodrigues; Clarisa B Palatnik-de-Sousa
Journal:  PLoS Negl Trop Dis       Date:  2010-11-09

5.  Improved canine and human visceral leishmaniasis immunodiagnosis using combinations of synthetic peptides in enzyme-linked immunosorbent assay.

Authors:  Míriam Maria Costa; Marcos Penido; Mariana Silva dos Santos; Daniel Doro; Eloísa de Freitas; Marilene Susan Marques Michalick; Gabriel Grimaldi; Ricardo Tostes Gazzinelli; Ana Paula Fernandes
Journal:  PLoS Negl Trop Dis       Date:  2012-05-22

6.  Immucillins Impair Leishmania (L.) infantum chagasi and Leishmania (L.) amazonensis Multiplication In Vitro.

Authors:  Elisangela Oliveira Freitas; Dirlei Nico; Rong Guan; José Roberto Meyer-Fernandes; Keith Clinch; Gary B Evans; Peter C Tyler; Vern L Schramm; Clarisa B Palatnik-de-Sousa
Journal:  PLoS One       Date:  2015-04-24       Impact factor: 3.240

7.  Resistance to visceral leishmaniasis is severely compromised in mice deficient of bradykinin B2-receptors.

Authors:  Dirlei Nico; Daniel Ferreira Feijó; Naiara Maran; Alexandre Morrot; Julio Scharfstein; Marcos Palatnik; Clarisa Beatriz Palatnik-de-Sousa
Journal:  Parasit Vectors       Date:  2012-11-14       Impact factor: 3.876

8.  Vaccines for canine leishmaniasis.

Authors:  Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2012-04-17       Impact factor: 7.561

9.  Cross-Protective Immunity to Leishmania amazonensis is Mediated by CD4+ and CD8+ Epitopes of Leishmania donovani Nucleoside Hydrolase Terminal Domains.

Authors:  Dirlei Nico; Daniele Crespo Gomes; Marcus Vinícius Alves-Silva; Elisangela Oliveira Freitas; Alexandre Morrot; Diana Bahia; Marcos Palatnik; Mauricio M Rodrigues; Clarisa B Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2014-05-01       Impact factor: 7.561

10.  Leishmania donovani Nucleoside Hydrolase Terminal Domains in Cross-Protective Immunotherapy Against Leishmania amazonensis Murine Infection.

Authors:  Dirlei Nico; Daniele Crespo Gomes; Iam Palatnik-de-Sousa; Alexandre Morrot; Marcos Palatnik; Clarisa Beatriz Palatnik-de-Sousa
Journal:  Front Immunol       Date:  2014-06-11       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.